| ADORA2B |
ADORA2B: Adenosine receptor A2b |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.472 |
Evidence |
|
| TNFRSF7 |
CD27, TNFRSF7: CD27 antigen precursor |
TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
0.472 |
Evidence |
|
| FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
0.472 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
GPR12 |
GPR12: Probable G-protein coupled receptor 12 |
0.472 |
Evidence |
|
| CDH3 |
CDH3, CDHP: Cadherin-3 precursor |
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
0.472 |
Evidence |
|
| CXCL3 |
CXCL3, GRO3, GROG, SCYB3: Macrophage inflammatory protein 2-beta precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
0.472 |
Evidence |
|
| CXCL3 |
CXCL3, GRO3, GROG, SCYB3: Macrophage inflammatory protein 2-beta precursor |
ADORA2B |
ADORA2B: Adenosine receptor A2b |
0.472 |
Evidence |
|
| RHOQ |
RHOQ, ARHQ, RASL7A, TC10: Rho-related GTP-binding protein RhoQ precursor |
GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
0.472 |
Evidence |
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
CDH1 |
CDH1, CDHE, UVO: Epithelial cadherin precursor |
0.472 |
Evidence |
O
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
CDH3 |
CDH3, CDHP: Cadherin-3 precursor |
0.472 |
Evidence |
|
| CCL3 |
CCL3, G0S19-1, MIP1A, SCYA3: Small-inducible cytokine A3 precursor |
GPR65 |
GPR65, TDAG8: Psychosine receptor |
0.472 |
Evidence |
|
| CCL3 |
CCL3, G0S19-1, MIP1A, SCYA3: Small-inducible cytokine A3 precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
0.472 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
GPR109B |
GPR109B: Nicotinic acid receptor 2 |
0.472 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
CCR1 |
CCR1, CMKBR1, CMKR1, SCYAR1: C-C chemokine receptor type 1 |
0.472 |
Evidence |
|
| CHRM5 |
CHRM5: Muscarinic acetylcholine receptor M5 |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.472 |
Evidence |
|
| EDN1 |
EDN1: Endothelin-1 precursor |
ECE1 |
ECE1: Endothelin-converting enzyme 1 |
0.472 |
Evidence |
|
| CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
MC1R |
IPI00552844 |
0.472 |
Evidence |
|
| PF4 |
PF4, CXCL4, SCYB4: Platelet factor 4 precursor |
GPR109B |
GPR109B: Nicotinic acid receptor 2 |
0.472 |
Evidence |
|
| PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
GPR109B |
GPR109B: Nicotinic acid receptor 2 |
0.472 |
Evidence |
|
| PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
CCR1 |
CCR1, CMKBR1, CMKR1, SCYAR1: C-C chemokine receptor type 1 |
0.472 |
Evidence |
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
0.472 |
Evidence |
|
| DDX58 |
DDX58: Probable ATP-dependent RNA helicase DDX58 |
QRICH1 |
IPI00328200 |
0.472 |
Evidence |
|
| DEDD |
DEDD, DEDPRO1, KE05, DEFT: Death effector domain-containing protein |
MYD88 |
|
0.472 |
Evidence |
|
| DEDD |
DEDD, DEDPRO1, KE05, DEFT: Death effector domain-containing protein |
FADD |
FADD, MORT1: Protein FADD |
0.472 |
Evidence |
|
| VAMP4 |
VAMP4: Vesicle-associated membrane protein 4 |
STX8 |
STX8: Syntaxin-8 |
0.472 |
Evidence |
|